Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005169606 | SCV005803224 | pathogenic | not provided | 2024-02-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val341Alafs*31) in the SLCO2A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLCO2A1 are known to be pathogenic (PMID: 22553128, 23509104). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLCO2A1-related conditions. For these reasons, this variant has been classified as Pathogenic. |